194 related articles for article (PubMed ID: 29501726)
1. Extracellular nucleotides enhance agonist potency at the parathyroid hormone 1 receptor.
Kim BH; Pereverzev A; Zhu S; Tong AOM; Dixon SJ; Chidiac P
Cell Signal; 2018 Jun; 46():103-112. PubMed ID: 29501726
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone potentiates nucleotide-induced [Ca2+]i release in rat osteoblasts independently of Gq activation or cyclic monophosphate accumulation. A mechanism for localizing systemic responses in bone.
Buckley KA; Wagstaff SC; McKay G; Gaw A; Hipskind RA; Bilbe G; Gallagher JA; Bowler WB
J Biol Chem; 2001 Mar; 276(12):9565-71. PubMed ID: 11124938
[TBL] [Abstract][Full Text] [Related]
3. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
[TBL] [Abstract][Full Text] [Related]
4. Extracellular nucleotides potentiate the cytosolic Ca2+, but not cyclic adenosine 3', 5'-monophosphate response to parathyroid hormone in rat osteoblastic cells.
Kaplan AD; Reimer WJ; Feldman RD; Dixon SJ
Endocrinology; 1995 Apr; 136(4):1674-85. PubMed ID: 7895678
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X
Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
7. Toward Defining the Pharmacophore for Positive Allosteric Modulation of PTH1 Receptor Signaling by Extracellular Nucleotides.
Kim BH; Wang FI; Pereverzev A; Chidiac P; Dixon SJ
ACS Pharmacol Transl Sci; 2019 Jun; 2(3):155-167. PubMed ID: 32259054
[TBL] [Abstract][Full Text] [Related]
8. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
[TBL] [Abstract][Full Text] [Related]
9. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50).
Sneddon WB; Syme CA; Bisello A; Magyar CE; Rochdi MD; Parent JL; Weinman EJ; Abou-Samra AB; Friedman PA
J Biol Chem; 2003 Oct; 278(44):43787-96. PubMed ID: 12920119
[TBL] [Abstract][Full Text] [Related]
10. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
Vilardaga JP; Lin I; Nissenson RA
Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
[TBL] [Abstract][Full Text] [Related]
11. PTH1 receptor is involved in mediating cellular response to long-chain polyunsaturated fatty acids.
Candelario J; Tavakoli H; Chachisvilis M
PLoS One; 2012; 7(12):e52583. PubMed ID: 23300710
[TBL] [Abstract][Full Text] [Related]
12. Arrestins in bone.
Bohinc BN; Gesty-Palmer D
Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
[TBL] [Abstract][Full Text] [Related]
13. Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization.
Bisello A; Manen D; Pierroz DD; Usdin TB; Rizzoli R; Ferrari SL
Mol Endocrinol; 2004 Jun; 18(6):1486-98. PubMed ID: 14988434
[TBL] [Abstract][Full Text] [Related]
14. Conditionally immortalized murine osteoblasts lacking the type 1 PTH/PTHrP receptor.
Divieti P; Lanske B; Kronenberg HM; Bringhurst FR
J Bone Miner Res; 1998 Dec; 13(12):1835-45. PubMed ID: 9844101
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.
Culhane KJ; Belina ME; Sims JN; Cai Y; Liu Y; Wang PSP; Yan ECY
ACS Chem Biol; 2018 Aug; 13(8):2347-2358. PubMed ID: 29952553
[TBL] [Abstract][Full Text] [Related]
16. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
Yang Y; Wang B
Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
[TBL] [Abstract][Full Text] [Related]
17. PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway.
Martin TJ
Front Endocrinol (Lausanne); 2021; 12():833221. PubMed ID: 35126319
[TBL] [Abstract][Full Text] [Related]
18. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
Bohinc BN; Gesty-Palmer D
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
[TBL] [Abstract][Full Text] [Related]
19. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization.
Sneddon WB; Friedman PA
Endocrinology; 2007 Aug; 148(8):4073-9. PubMed ID: 17525124
[TBL] [Abstract][Full Text] [Related]
20. Brief exposure to full length parathyroid hormone-related protein (PTHrP) causes persistent generation of cyclic AMP through an endocytosis-dependent mechanism.
Ho PWM; Chan AS; Pavlos NJ; Sims NA; Martin TJ
Biochem Pharmacol; 2019 Nov; 169():113627. PubMed ID: 31476292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
